Penn Medicine Provider
Urology
Phillip M. Pierorazio, MD
5.0
(435)
Accepting new patients
Sees patients age 18 and up
Penn Urology University City
View 2 additional locations
Make an appointmentCall 215-662-8699

About me

  • Chief, Section of Urology, Penn Presbyterian Medical Center
  • Professor of Surgery at the Hospital of the University of Pennsylvania

I am a board-certified urologist with training and expertise in urologic cancers.  I have expertise in all malignancies of the urinary tract, but my clinical and academic practice focuses on kidney cancer (renal cell carcinoma), testicular cancer (germ cell tumors), upper tract urothelial cancer, and prostate cancer.  I offer patients both open and minimally invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder, prostate, and retroperitoneal lymph node dissection for testicular cancer.  I am a firm believer that surgery is a last option and prefer non-operative management whenever possible – but routinely perform surgeries for complex cancers and patients. 

My research team includes basic science researchers, statisticians, and other urologists both inside and outside Penn Medicine.  We focus on cancer biomarkers, improving outcomes for complex surgeries, evaluating the quality of care through a cancer journey, and minimizing the impact of surgical treatments.  I run the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry - one of the largest active surveillance registries for patients with small kidney tumors. I am involved in a number of national guideline panels, including both the American Urological Association (AUA) and National Comprehensive Cancer Network (NCCN) Guidelines Committees, for Kidney, Testicular and Upper Tract Urothelial Cancer. 

While I experience tremendous satisfaction from generating research and guidelines that influence the care of cancer patients around the world, in my opinion, there is no greater impact in medicine than taking a patient through a cancer journey.  My greatest joy comes from the relationships we build through diagnosis, treatment, and the survivorship journey.

Education and training

  • Medical School: Columbia University
  • Residency: Johns Hopkins Hospital

What my patients think about me

Average Rating
5.0

435 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
excellent service
May 2025
5.0
5.0
expertise
May 2025
5.0
5.0
great dr
May 2025
5.0
5.0
doctor was direct and open and provided us with encouraging information

Insurance accepted

My Locations

Learn about location
Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Pierorazio is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

My research

Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP Reply by authors , Journal of Urology: 2022 (Epub)

Patel HV, Srivastava A, Kim S, Patel HD, Pierorazio PM, Bagrodia A, Masterson TA, Ghodoussipour SB, Kim IY, Singer EA, Jang TL Association of lymph node count and survival after primary retroperitoneal lymphadenectomy for non-seminomatous testicular cancer , Journal of Urology: 2022 (Epub)

Delto JC, Fleishman A, Chang P, Jiang DD, Hyde S, McAnally K, Crociani C, Jamil M, Patel HD, Pavlinec J, Budzyn J, Durant A, Eilender B, Gordon AO, Huang MM, Pierorazio PM, Raman JD, Rogers C, Su LM, Wagner AA Perioperative aspirin use is associated with bleeding complications during robotic partial nephrectomy , Journal of Urology, 207(2): 2022,277-283

Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report , Journal of Urology: 2021 (Epub)

Psutka SP, Gulati R, Jewett MAS, Fadaak K, Finelli A, Legere L, Morgan TM, Pierorazio PM, Allaf ME, Herrin J, Lohse CM, Houston Thompson R, Boorjian SA, Atwell TD, Schmit GD, Costello BA, Shah ND, Leibovich BC A clinical decision aid to support personalized treatment selection for patients with clinical T1 renal masses: Results from a multi-institutional competing-risks analysis- , European Urology: 2021 (Epub)

Metcalf MR, Peña VN, Cheaib JG, Srivastava A, Pierorazio PM, Patel HD Disparities in the treatment and survival of metastatic renal cell carcinoma , Urology: 2021 (Epub)

Patel SH, Wang S, Metcalf MR, Gupta N, Gabrielson A, Lee E, Rostom M, Pierorazio P, Smith A, Hahn N, Schoenberg M, Kates M, Hoffman-Censits J, Bivalacqua TJ Safety and efficacy of reproductive organ-sparing radical cystectomy in women with variant histology and advanced stage , Clinical Genitourinary Cancer: 2021 (Epub)

Alam R, Patel HD, Su ZT, Cheaib JG, Ged Y, Singla N, Allaf ME, Pierorazio PM Self-reported quality of life as a predictor of mortality in renal cell carcinoma , Cancer: 2021 (Epub)

Gorin MA, Patel HD, Rowe SP, Hahn NM, Hammers HJ, Pons A, Trock BJ, Pierorazio PM, Nirschl TR, Salles DC, Stein JE, Lotan TL, Taube JM, Drake CG, Allaf ME Neoadjuvant Nivolumab in patients with high-risk nonmetastatic renal cell carcinoma , European Urologic Oncology: 2021 (Epub)

Marcq G, Foerster B, Abufaraj M, Matin SF, Azizi M, Gupta M, Li WM, Seisen T, Clinton T, Xylinas E, Mir MC, Schweitzer D, Mari A, Kimura S, Bandini M, Mathieu R, Ku JH, Guruli G, Grabbert M, Czech AK, Muilwijk T, Pycha A, D'Andrea D, Petros FG, Spiess PE, Bivalacqua T, Wu WJ, Roupret M, Krabbe LM, Hendricksen K, Egawa S, Briganti A, Moschini M, Graffeille V, Autorino R, John P, Heidenreich A, Chlosta P, Joniau S, Soria F, Pierorazio PM, Shariat SF, Kassouf W Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney-sparing strategies: An international collaborative study , European Urology Focus: 2021 (Epub)

View all publications